Previous Page  10 / 23 Next Page
Information
Show Menu
Previous Page 10 / 23 Next Page
Page Background

Page 28

Notes:

Volume 3

Journal of Nursing Research and Practice

Nursing and Heart 2019

April 22-23, 2019

Nursing Education and Evidence Based Practice Conference

Heart Conference

April 22-23, 2019 Dubai, UAE

World

4

th

International

&

The challenges in managing Heart Failure with preserved Ejection Fraction (HFpEF)

Samer Ellahham

Cleveland Clinic, UAE

H

eart failure is a life‐threatening disease and addressing it should be considered a global health priority. Approximately half of all

patients with Heart Failure have preserved Ejection Fraction (HFpEF) and, as life expectancies continue to increase in western

societies, the prevalence of HFpEF will continue to grow. In contrast to Heart Failure with preserved Ejection Fraction (HFrEF), no

treatment has been proven in pivotal clinical trials to be effective for HFpEF, largely because of the pathophysiological heterogeneity

that exists within the broad spectrum of HFpEF. This syndrome was historically considered to be caused exclusively by left ventricular

diastolic dysfunction, but research has identified several other contributory factors, including limitations in left ventricular systolic

reserve, systemic and pulmonary vascular function, nitric oxide bioavailability, chronotropic reserve, right heart function, autonomic

tone, left atrial function, and peripheral impairments. Multiple individual mechanisms frequently coexist within the same patient

to cause symptomatic heart failure, but between patients with HFpEF the extent to which each component is operative can differ

widely, confounding treatment approaches. This lecture focuses on our current understanding of the pathophysiological mechanisms

underlying HFpEF, and how they might be mechanistically related to typical risk factors for HFpEF, including ageing, obesity, and

hypertension.

Biography

Samer Ellahham is a board-certified Internist, Cardiologist and Vascular Medicine Senior Consultant. He is a Fellow of the American College of Cardiology and

key member in heart failure and transplant, adult congenital and pediatric cardiology, cardio-oncology and peripheral vascular disease sections. He is the Eminent

Editor of The Journal of Cardiology & Cardiovascular Therapy. He has served as Chief Quality Officer for SKMC since 2009. His research includes innovation, digital

healthcare solutions, telemedicine, block chain, patient experience and engagement, lean six sigma, change management, innovation, safety, risk management,

KPI management, safe surgery, heart failure, molecular biology, genetics, cardiac imaging, sports and nutrition. He is a recognized world-leader in these fields.

samerellahham@yahoo.com

Samer Ellahham, J Nursing Research and Practice, Volume 3

DOI: 10.4172/2632-251X-C3-008